Inanovate was founded in Massachusetts by two Babson MBA graduates, after winning first prize at the Babson Business Plan competition. The company has since grown operations in Massachusetts, North Carolina and the UK, forming close alliances with leading commercial and academic institutions. Inanovate has combined expertise from nano-scale physics, bio-engineering, bio-chemistry and biotechnology to create a unique mutliplexed protein screening technology called Longitudinal Assay Screening (LAS), designed to help advance the development and implementation of next generation therapeutics and clinical diagnostics. Inanovate has recently completed testing and demonstration of the world's first protein detection and measurement platform to integrate LAS - The Bio-ID 400. Inanovate is now seeking to build on it's technical and commercial foundations through partnerships with companies seeking to develop, validate and launch multiplexed protein assays for selected research or clinical applications. For more information please visit: http://www.inanovate.com
Inanovate Address
2 Davis Drive Research Triangle Park, NC United States